![]() |
|
|
Vol. 280, Issue 1, 138-145, 1997
Department of Pharmacology and Experimental Therapeutics, Loyola
University of Chicago, Stritch School of Medicine, Maywood, Illinois
The present study examines the consequences of prenatal fluoxetine
exposure on brain serotonin [5-hydroxytryptamine (5-HT)] neurons in
male offspring. Pregnant rats were administered either saline or
fluoxetine (10 mg/kg s.c.) daily from gestational day 13 through
gestational day 20. The biochemical status of brain 5-HT neurons was
assessed in prepubescent and adult offspring by measuring 1) the 5-HT
and 5-hydroxyindoleacetic acid content, 2) the density of
[3H]paroxetine-labeled 5-HT uptake sites and 3) the
ability of the 5-HT-releasing drug p-chloroamphetamine
to reduce 5-HT content. Biochemical parameters were assessed in the
frontal cortex, hypothalamus, hippocampus, striatum and midbrain.
Comparative effects on dopamine and norepinephrine content in selected
regions were also determined. Prenatal exposure to fluoxetine
significantly reduced (
28%) 5-HT content in the frontal cortex of
prepubescent but not adult male offspring. In contrast, in adult
progeny prenatal fluoxetine exposure produced a significant decrease
only in midbrain 5-HT content (
28%). In addition,
p-chloroamphetamine markedly reduced 5-HT content in all
brain regions examined, but the ability of
p-chloroamphetamine to reduce 5-HT content was
significantly attenuated only in the midbrain of adult progeny
prenatally exposed to fluoxetine. No significant differences were
observed between control and fluoxetine-exposed progeny with respect to
brain 5-hydroxyindoleacetic acid content, the 5-hydroxyindoleacetic
acid/5-HT ratio or the density of 5-HT uptake sites, regardless of the
brain region examined or the age of the offspring. These data provide
additional evidence that prenatal exposure to fluoxetine can produce
limited, rather than global, changes in brain 5-HT neurons in male rat
offspring and that the effects observed are region-specific and
age-dependent. The potential functional consequences and clinical
implications of these alterations in brain 5-HT systems remain to be
elucidated.
This article has been cited by other articles:
![]() |
T. F. Oberlander, R. E. Grunau, C. Fitzgerald, M. Papsdorf, D. Rurak, and W. Riggs Pain Reactivity in 2-Month-Old Infants After Prenatal and Postnatal Selective Serotonin Reuptake Inhibitor Medication Exposure Pediatrics, February 1, 2005; 115(2): 411 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Costa, L. Steardo, and V. Cuomo Structural Effects and Neurofunctional Sequelae of Developmental Exposure to Psychotherapeutic Drugs: Experimental and Clinical Aspects Pharmacol. Rev., March 1, 2004; 56(1): 103 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Cabrera-Vera and G. Battaglia Prenatal Exposure to Fluoxetine (Prozac) Produces Site-Specific and Age-Dependent Alterations in Brain Serotonin Transporters in Rat Progeny: Evidence from Autoradiographic Studies J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1474 - 1481. [Abstract] [Full Text] |
||||
![]() |
D. Bengel, D. L. Murphy, A. M. Andrews, C. H. Wichems, D. Feltner, A. Heils, R. Mössner, H. Westphal, and K.-P. Lesch Altered Brain Serotonin Homeostasis and Locomotor Insensitivity to 3,4-Methylenedioxymethamphetamine ("Ecstasy") in Serotonin Transporter-Deficient Mice Mol. Pharmacol., April 1, 1998; 53(4): 649 - 655. [Abstract] [Full Text] |
||||